The European Commission announced on Friday that it plans to give Malta a three-year reprieve from medicines import rules to help lessen Brexit pressure on local distributors.
The proposals are a means to ensure the continued supply of medicines from the UK to Malta as well as Cyprus and Ireland. Malta will be benefitting from a number of derogations and exemptions for a three-year period if implemented.
Medicines from the UK will not, for that period, require manufacturing authorisations nor new batch testing if already tested to be allowed into the country. The plan will need approval by the European Parliament and EU leaders.
With Malta historically relying on imports of medicines from the UK, the arrangement was put into muddy waters due to UK’s exit from the EU. The UK is now considered a third country by the EU and thus no longer part of the single market for pharmaceuticals.
#MaltaDaily
Photo Source: Dachser